KleanLyte is developed by University of Manitoba.

What development phase is KleanLyte in?

KleanLyte is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

KleanLyte

University of Manitoba · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	KleanLyte
Sponsor	University of Manitoba
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

KleanLyte CI brief — competitive landscape report
KleanLyte updates RSS · CI watch RSS
University of Manitoba portfolio CI